Cargando…
Patient Attributes Associated With Better Long-Term Outcomes on Palliative Milrinone
Milrinone is a phosphodiesterase three inhibitor used as an inotrope in patients with advanced heart failure with reduced ejection fraction (HFrEF). Its action is independent of β-receptor stimulation, which makes it preferable in patients who are on β blockers as part of a guideline-directed neuroh...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Cureus
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273353/ https://www.ncbi.nlm.nih.gov/pubmed/32523836 http://dx.doi.org/10.7759/cureus.7979 |